Literature DB >> 8090467

Diagnostic management by gatekeepers is not cost effective for neuro-ophthalmology.

E C Dillon1, R C Sergott, P J Savino, T M Bosley.   

Abstract

PURPOSE: To determine whether the "gatekeeper physician system" for evaluating neuro-ophthalmologic problems is cost effective.
METHODS: The authors retrospectively reviewed the records of 588 patients referred for neuro-ophthalmologic evaluation between July and December 1989 to determine the frequency and cost of unnecessary diagnostic testing ordered by "gatekeeper physicians." Pre-referral diagnostic testing costs were compared with the cost of neurophthalmologic consultation for four common problems: (1) optic neuropathy; (2) diplopia; (3) ptosis; and (4) proptosis.
RESULTS: Between 16% and 26% of patients in the first three diagnostic categories were subjected to overtesting, resulting in $57,900 of excessive costs, a 724% overcharge. Although the evaluation of proptosis was performed correctly, the quality of 10 of the 18 neuro-imaging procedures was substandard.
CONCLUSIONS: The gatekeeper system managed by primary care physicians for these four neuro-ophthalmologic problems not only did not conserve healthcare dollars but also had a negative impact on cost control. For neuro-ophthalmologic disorders, prompt subspecialty evaluation and examination appear to be a cost-effective strategy.

Entities:  

Mesh:

Year:  1994        PMID: 8090467     DOI: 10.1016/s0161-6420(94)31127-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  2 in total

1.  The influence of gatekeeping and utilization review on patient satisfaction.

Authors:  E A Kerr; R D Hays; A Mitchinson; M Lee; A L Siu
Journal:  J Gen Intern Med       Date:  1999-05       Impact factor: 5.128

Review 2.  Diagnostic Error in Neuro-ophthalmology: Avenues to Improve.

Authors:  Elena A Muro-Fuentes; Leanne Stunkel
Journal:  Curr Neurol Neurosci Rep       Date:  2022-03-23       Impact factor: 6.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.